Legal Representation
Attorney
Alexander Reid
USPTO Deadlines
Next Deadline
1703 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-03-12)
Due Date
March 12, 2030
Grace Period Ends
September 12, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
22 eventsDate | Code | Type | Description |
---|---|---|---|
Mar 12, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
Mar 12, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
Feb 4, 2024 | ETOP | T | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
Oct 10, 2023 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED |
Sep 26, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION |
Sep 26, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Sep 6, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Aug 29, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Aug 29, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Aug 29, 2023 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
Aug 29, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Aug 21, 2023 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
Aug 3, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Aug 3, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Aug 1, 2023 | ALIE | A | ASSIGNED TO LIE |
Mar 24, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Feb 16, 2023 | DOCK | D | ASSIGNED TO EXAMINER |
Feb 16, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN |
Feb 16, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED |
Feb 16, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
May 3, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
May 2, 2022 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Sanitary preparations for medical purposes; Pharmaceuticals, namely, pharmaceutical preparations for the treatment of osteoarthritis, rheumatoid arthritis, diabetic neuropathy, peripheral neuropathy, small fibre neuropathy, trigeminal neuralgia, post herpetic neuralgia, post amputation neuropathic pain, post operative pain, cancer-related pain, trigger point pain, sciatica, overactive bladder syndrome, fibromyalgia syndrome, erythromelalgia; Medical preparations for the treatment of pain
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Translation
The wording ONMOVY has no meaning in a foreign language.
Classification
International Classes
005
USPTO Documents
Click to view cached USPTO documents for this trademark
Only administrators can request new documents from USPTO